Terms: = Bone cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Staging
6 results:
1. Chemokine Receptor PET/CT Provides Relevant staging and Management Changes in Marginal Zone Lymphoma.
Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
[TBL] [Abstract] [Full Text] [Related]
2. FDG-PET imaging in hematological malignancies.
Valls L; Badve C; Avril S; Herrmann K; Faulhaber P; O'Donnell J; Avril N
Blood Rev; 2016 Jul; 30(4):317-31. PubMed ID: 27090170
[TBL] [Abstract] [Full Text] [Related]
3. Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.
Li XX; Li RJ; Zhao LJ; Liu NB; Wang P
Int J Clin Exp Pathol; 2015; 8(11):14676-84. PubMed ID: 26823791
[TBL] [Abstract] [Full Text] [Related]
4. [Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].
Li RJ; Zhao LJ; Zhan ZL; Lü X; Gong LL; Wang P
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):532-5. PubMed ID: 22490156
[TBL] [Abstract] [Full Text] [Related]
5. Clincopathological analysis of olfactory neuroblastoma.
Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
[TBL] [Abstract] [Full Text] [Related]
6. If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.
Mancuso P; Calleri A; Antoniotti P; Quarna J; Pruneri G; Bertolini F
BMC Cancer; 2010 Nov; 10():644. PubMed ID: 21106070
[TBL] [Abstract] [Full Text] [Related]
